{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:30:03Z","timestamp":1782246603962,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04542-x","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:26:39Z","timestamp":1746332799000},"page":"3671-3685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures: an updated systematic review and meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Ahmed Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zubair","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanz Ul Eman","family":"Maryam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Uzair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Haram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6878-2031","authenticated-orcid":false,"given":"Muhammad Shaheer Bin","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zainab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish Ali","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Kaleem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidrah","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sameer","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,4]]},"reference":[{"key":"4542_CR1","doi-asserted-by":"publisher","first-page":"E139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ et al (2020) Heart disease and stroke statistics\u20142020 update: a report from the American heart association. Circulation 141:E139\u2013E596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"#cr-split#-4542_CR2.1","unstructured":"Manda YR, Baradhi KM (2023) Cardiac Catheterization Risks and Complications. In: StatPearls [Internet]."},{"key":"#cr-split#-4542_CR2.2","unstructured":"Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID:30285356."},{"key":"4542_CR3","doi-asserted-by":"publisher","first-page":"p65","DOI":"10.5539\/GJHS.V4N1P65","volume":"4","author":"M Tavakol","year":"2012","unstructured":"Tavakol M, Ashraf S, Brener SJ (2012) Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci 4:p65. https:\/\/doi.org\/10.5539\/GJHS.V4N1P65","journal-title":"Glob J Health Sci"},{"key":"4542_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/S11255-018-1874-1\/METRICS","volume":"50","author":"S Hiremath","year":"2018","unstructured":"Hiremath S, Akbari A, Wells GA, Chow BJW (2018) Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis. Int Urol Nephrol 50:1477\u20131482. https:\/\/doi.org\/10.1007\/S11255-018-1874-1\/METRICS","journal-title":"Int Urol Nephrol"},{"key":"4542_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718803677","author":"G Sun","year":"2018","unstructured":"Sun G, Chen P, Wang K et al (2018) Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. https:\/\/doi.org\/10.1177\/0003319718803677","journal-title":"Angiology"},{"key":"4542_CR6","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.amjcard.2017.08.036","volume":"120","author":"M Abe","year":"2017","unstructured":"Abe M, Morimoto T, Nakagawa Y et al (2017) Impact of transient or persistent contrast-induced nephropathy on long-term mortality after elective percutaneous coronary intervention. Am J Cardiol 120:2146\u20132153. https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.036","journal-title":"Am J Cardiol"},{"key":"4542_CR7","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/S00330-011-2225-0\/METRICS","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul F, Van Der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527\u20132541. https:\/\/doi.org\/10.1007\/S00330-011-2225-0\/METRICS","journal-title":"Eur Radiol"},{"key":"4542_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/CC11455\/FIGURES\/1","volume":"17","author":"N Lameire","year":"2013","unstructured":"Lameire N, Kellum JA, Aspelin P et al (2013) Contrast-induced acute kidney injury and renal support for acute kidney injury: A KDIGO summary (Part 2). Crit Care 17:1\u201313. https:\/\/doi.org\/10.1186\/CC11455\/FIGURES\/1","journal-title":"Crit Care"},{"key":"4542_CR9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/S00330-017-5246-5\/TABLES\/3","volume":"28","author":"AJ van der Molen","year":"2018","unstructured":"van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury\u2014Part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR contrast medium safety committee guidelines. Eur Radiol 28:2845\u20132855. https:\/\/doi.org\/10.1007\/S00330-017-5246-5\/TABLES\/3","journal-title":"Eur Radiol"},{"key":"4542_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5114\/AIC.2018.74356","volume":"14","author":"B Biernacka-Fia\u0142kowska","year":"2018","unstructured":"Biernacka-Fia\u0142kowska B, Szuksztul M, Su\u015blik W et al (2018) Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy\u2014a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial. Adv Interv Cardiol\/Post\u0119py w Kardiologii Interwencyjnej 14:59\u201366. https:\/\/doi.org\/10.5114\/AIC.2018.74356","journal-title":"Adv Interv Cardiol\/Post\u0119py w Kardiologii Interwencyjnej"},{"key":"4542_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.amjmed.2014.05.011","volume":"127","author":"S Gandhi","year":"2014","unstructured":"Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME (2014) Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med 127:987\u20131000. https:\/\/doi.org\/10.1016\/j.amjmed.2014.05.011","journal-title":"Am J Med"},{"key":"4542_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110766","author":"P Paolisso","year":"2023","unstructured":"Paolisso P, Bergamaschi L, Cesaro A et al (2023) Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry. Diabetes Res Clin Pract. https:\/\/doi.org\/10.1016\/j.diabres.2023.110766","journal-title":"Diabetes Res Clin Pract"},{"key":"4542_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1253\/CIRCJ.CJ-16-0921","volume":"81","author":"K Komiyama","year":"2017","unstructured":"Komiyama K, Ashikaga T, Inagaki D et al (2017) Sodium bicarbonate-ascorbic acid combination for prevention of contrast-induced nephropathy in chronic kidney disease patients undergoing catheterization. Circ J 81:235\u2013240. https:\/\/doi.org\/10.1253\/CIRCJ.CJ-16-0921","journal-title":"Circ J"},{"key":"4542_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003720","author":"W Huber","year":"2016","unstructured":"Huber W, Huber T, Baum S et al (2016) Sodium bicarbonate prevents contrast-induced nephropathy in addition to theophylline. Medicine (United States). https:\/\/doi.org\/10.1097\/MD.0000000000003720","journal-title":"Medicine (United States)"},{"key":"4542_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/RLI.0B013E3181D2EED8","volume":"45","author":"SN Heyman","year":"2010","unstructured":"Heyman SN, Rosen S, Khamaisi M et al (2010) Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 45:188\u2013195. https:\/\/doi.org\/10.1097\/RLI.0B013E3181D2EED8","journal-title":"Invest Radiol"},{"key":"4542_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12882-024-03570-6\/TABLES\/1","volume":"25","author":"Y Li","year":"2024","unstructured":"Li Y, Wang J (2024) Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment. BMC Nephrol 25:1\u201314. https:\/\/doi.org\/10.1186\/S12882-024-03570-6\/TABLES\/1","journal-title":"BMC Nephrol"},{"key":"4542_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMOA1710933\/SUPPL_FILE\/NEJMOA1710933_DISCLOSURES.PDF","volume":"378","author":"SD Weisbord","year":"2018","unstructured":"Weisbord SD, Gallagher M, Jneid H et al (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378:603\u2013614. https:\/\/doi.org\/10.1056\/NEJMOA1710933\/SUPPL_FILE\/NEJMOA1710933_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"4542_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/CPT.2541","volume":"111","author":"EA Sandilands","year":"2022","unstructured":"Sandilands EA, Rees JMB, Raja K et al (2022) Acetylcysteine has no mechanistic effect in patients at risk of contrast-induced nephropathy: a failure of academic clinical science. Clin Pharmacol Ther 111:1222\u20131238. https:\/\/doi.org\/10.1002\/CPT.2541","journal-title":"Clin Pharmacol Ther"},{"key":"4542_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-017-1862-3\/FIGURES\/5","volume":"21","author":"E Palli","year":"2017","unstructured":"Palli E, Makris D, Papanikolaou J et al (2017) The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study. Crit Care 21:1\u20139. https:\/\/doi.org\/10.1186\/S13054-017-1862-3\/FIGURES\/5","journal-title":"Crit Care"},{"key":"4542_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/1744-9987.12083","volume":"17","author":"B Dvor\u0161ak","year":"2013","unstructured":"Dvor\u0161ak B, Kani\u010d V, Ekart R et al (2013) Ascorbic acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial. Ther Apher Dial 17:384\u2013390. https:\/\/doi.org\/10.1111\/1744-9987.12083","journal-title":"Ther Apher Dial"},{"key":"4542_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/J.1476-5381.2011.01231.X","volume":"163","author":"S Shimizu","year":"2011","unstructured":"Shimizu S, Saito M, Kinoshita Y et al (2011) Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br J Pharmacol 163:272\u2013282. https:\/\/doi.org\/10.1111\/J.1476-5381.2011.01231.X","journal-title":"Br J Pharmacol"},{"key":"4542_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/FJC.0000000000001117","volume":"78","author":"X Du","year":"2021","unstructured":"Du X, Ma Z, Li L, Zhong X (2021) Nicorandil decreases renal injury in patients with coronary heart disease complicated with type i cardiorenal syndrome. J Cardiovasc Pharmacol 78:675\u2013680. https:\/\/doi.org\/10.1097\/FJC.0000000000001117","journal-title":"J Cardiovasc Pharmacol"},{"key":"4542_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E28922","author":"D Singh","year":"2024","unstructured":"Singh D, Singh R, Akindele AJ (2024) Therapeutic potential of nicorandil beyond anti-anginal drug: a review on current and future perspectives. Heliyon. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E28922","journal-title":"Heliyon"},{"key":"4542_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/J.JCLINEPI.2009.06.006\/ASSET\/C5E18D15-B558-409B-A265-7D4F0D83D365\/MAIN.ASSETS\/GR1.JPG","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1\u2013e34. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2009.06.006\/ASSET\/C5E18D15-B558-409B-A265-7D4F0D83D365\/MAIN.ASSETS\/GR1.JPG","journal-title":"J Clin Epidemiol"},{"key":"4542_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/0378-6323.25654","volume":"72","author":"BR Eapen","year":"2006","unstructured":"Eapen BR (2006) EndNote 7.0. Indian J Dermatol Venereol Leprol 72:165\u2013166. https:\/\/doi.org\/10.4103\/0378-6323.25654","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4542_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/S42399-020-00584-7","author":"VP Papadopoulos","year":"2020","unstructured":"Papadopoulos VP, Apergis N, Filippou DK (2020) Nocturia in CPAP-treated obstructive sleep apnea patients: a systematic review and meta-analysis. SN Compr Clin Med. https:\/\/doi.org\/10.1007\/S42399-020-00584-7","journal-title":"SN Compr Clin Med"},{"key":"4542_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.JPSYCHIRES.2015.01.003","volume":"62","author":"A McGirr","year":"2015","unstructured":"McGirr A, Berlim MT, Bond DJ et al (2015) A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. J Psychiatr Res 62:23\u201330. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2015.01.003","journal-title":"J Psychiatr Res"},{"key":"4542_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.JPSYCHIRES.2017.02.015","volume":"90","author":"MT Berlim","year":"2017","unstructured":"Berlim MT, McGirr A, Rodrigues dos Santos N et al (2017) Efficacy of theta burst stimulation (TBS) for major depression: an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 90:102\u2013109. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2017.02.015","journal-title":"J Psychiatr Res"},{"key":"4542_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/CAMH.12113","volume":"20","author":"K Kallapiran","year":"2015","unstructured":"Kallapiran K, Koo S, Kirubakaran R, Hancock K (2015) Review: Effectiveness of mindfulness in improving mental health symptoms of children and adolescents: a meta-analysis. Child Adolesc Ment Health 20:182\u2013194. https:\/\/doi.org\/10.1111\/CAMH.12113","journal-title":"Child Adolesc Ment Health"},{"key":"4542_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/EJHF.3129","volume":"26","author":"MS Usman","year":"2024","unstructured":"Usman MS, Januzzi JL, Anker SD et al (2024) The effect of sodium\u2013glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis. Eur J Heart Fail 26:373\u2013382. https:\/\/doi.org\/10.1002\/EJHF.3129","journal-title":"Eur J Heart Fail"},{"key":"4542_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/APP12031593\/S1","volume":"12","author":"G Yagiz","year":"2022","unstructured":"Yagiz G, Akaras E, Kubis HP, Owen JA (2022) The effects of resistance training on architecture and volume of the upper extremity muscles: a systematic review of randomised controlled trials and meta-analyses. Appl Sci (Switzerland) 12:1593. https:\/\/doi.org\/10.3390\/APP12031593\/S1","journal-title":"Appl Sci (Switzerland)"},{"key":"4542_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/SIM.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/SIM.1186","journal-title":"Stat Med"},{"key":"4542_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/BMJ.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/BMJ.315.7109.629","journal-title":"BMJ"},{"key":"4542_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.D5928","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC et al (2011) The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.D5928","journal-title":"BMJ"},{"key":"4542_CR35","unstructured":"Wells G, Wells G, Shea B, et al (2014) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses"},{"key":"4542_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","volume":"129","author":"JL Brozek","year":"2021","unstructured":"Brozek JL, Canelo-Aybar C, Akl EA et al (2021) GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence\u2014An overview in the context of health decision-making. J Clin Epidemiol 129:138\u2013150. https:\/\/doi.org\/10.1016\/j.jclinepi.2020.09.018","journal-title":"J Clin Epidemiol"},{"key":"4542_CR37","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1159\/000503160","volume":"44","author":"Z Fan","year":"2019","unstructured":"Fan Z, Li Y, Ji H, Jian X (2019) Efficacy of oral nicorandil to prevent contrast-induced nephropathy in patients with chronic renal dysfunction undergoing an elective coronary procedure. Kidney Blood Press Res 44:1372\u20131382. https:\/\/doi.org\/10.1159\/000503160","journal-title":"Kidney Blood Press Res"},{"key":"4542_CR38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3349\/YMJ.2013.54.4.957","volume":"54","author":"YG Ko","year":"2013","unstructured":"Ko YG, Lee BK, Kang WC et al (2013) Preventive effect of pretreatment with intravenous Nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study). Yonsei Med J 54:957\u2013964. https:\/\/doi.org\/10.3349\/YMJ.2013.54.4.957","journal-title":"Yonsei Med J"},{"key":"4542_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.58675\/2682-339X.1724","volume":"4","author":"AE Ali","year":"2023","unstructured":"Ali AE, El-Yazal IS, Mansy AM et al (2023) Role of Nicorandil effect on contrast induced nephropathy in patients land for elective PCI. Al-Azhar Int Med J 4:1. https:\/\/doi.org\/10.58675\/2682-339X.1724","journal-title":"Al-Azhar Int Med J"},{"key":"4542_CR40","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/S11255-023-03541-0\/METRICS","volume":"55","author":"A Abdollahi Moghaddam","year":"2023","unstructured":"Abdollahi Moghaddam A, Baradaran Rahimi V, Morovatdar N et al (2023) Oral Nicorandil effectively attenuates the incidence of contrast-induced nephropathy in patients undergoing cardiac catheterization: a randomized, controlled, open-label clinical trial. Int Urol Nephrol 55:2327\u20132334. https:\/\/doi.org\/10.1007\/S11255-023-03541-0\/METRICS","journal-title":"Int Urol Nephrol"},{"key":"4542_CR41","doi-asserted-by":"publisher","unstructured":"Qian G, Chen S, Jiang X-S, et al (2023) Efficacy of Nicorandil in Preventing Contrast-Induced Nephropathy in Patients with ST-segment Elevation Myocardial Infarction undergoing Primary Percutaneous Coronary Intervention. available on research square.  https:\/\/doi.org\/10.21203\/RS.3.RS-3299495\/V1","DOI":"10.21203\/RS.3.RS-3299495\/V1"},{"key":"4542_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MCA.0000000000001347","volume":"35","author":"J Yusuf","year":"2024","unstructured":"Yusuf J, Prakash G, Safal S et al (2024) Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial. Coron Artery Dis 35:186\u2013192. https:\/\/doi.org\/10.1097\/MCA.0000000000001347","journal-title":"Coron Artery Dis"},{"key":"4542_CR43","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/S00380-016-0809-Y\/METRICS","volume":"31","author":"Y Fan","year":"2016","unstructured":"Fan Y, Wei Q, Cai J et al (2016) Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization. Heart Vessels 31:1776\u20131782. https:\/\/doi.org\/10.1007\/S00380-016-0809-Y\/METRICS","journal-title":"Heart Vessels"},{"key":"4542_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5603\/CJ.A2017.0028","volume":"24","author":"L Iranirad","year":"2017","unstructured":"Iranirad L, Hejazi SF, Sadeghi MS, Jang SA (2017) Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: a prospective randomized controlled trial. Cardiol J 24:502\u2013507. https:\/\/doi.org\/10.5603\/CJ.A2017.0028","journal-title":"Cardiol J"},{"key":"4542_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijcard.2015.05.078","volume":"195","author":"T Nawa","year":"2015","unstructured":"Nawa T, Nishigaki K, Kinomura Y et al (2015) Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function. Int J Cardiol 195:228\u2013234. https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.078","journal-title":"Int J Cardiol"},{"key":"4542_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MCA.0000000000000826","volume":"31","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yang S, Zhang P, Fu N (2020) Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention. Coron Artery Dis 31:284\u2013288. https:\/\/doi.org\/10.1097\/MCA.0000000000000826","journal-title":"Coron Artery Dis"},{"key":"4542_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/0003319719841733","author":"P Zhang","year":"2019","unstructured":"Zhang P, Li WY, Yang SC et al (2019) Preventive effects of nicorandil against contrast-induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention. Angiology. https:\/\/doi.org\/10.1177\/0003319719841733","journal-title":"Angiology"},{"key":"4542_CR48","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/S11255-019-02244-9\/METRICS","volume":"51","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Fu XF, Zhang X, Fu N (2019) Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization. Int Urol Nephrol 51:1999\u20132004. https:\/\/doi.org\/10.1007\/S11255-019-02244-9\/METRICS","journal-title":"Int Urol Nephrol"},{"key":"4542_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","volume":"103","author":"PA McCullough","year":"1997","unstructured":"McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368\u2013375. https:\/\/doi.org\/10.1016\/S0002-9343(97)00150-2","journal-title":"Am J Med"},{"key":"4542_CR50","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/J.CARREV.2020.01.010","volume":"21","author":"R Pranata","year":"2020","unstructured":"Pranata R, Vania R, Alkatiri AA et al (2020) Nicorandil reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography\/intervention\u2014systematic review and meta-analysis of randomized controlled trials including GRADE qualification. Cardiovasc Revasc Med 21:1121\u20131127. https:\/\/doi.org\/10.1016\/J.CARREV.2020.01.010","journal-title":"Cardiovasc Revasc Med"},{"key":"4542_CR51","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.18632\/ONCOTARGET.23965","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Geng J, Zhu H et al (2018) Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials. Oncotarget 9:11837\u201311845. https:\/\/doi.org\/10.18632\/ONCOTARGET.23965","journal-title":"Oncotarget"},{"key":"4542_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/S12882-023-03194-2","author":"T Takura","year":"2023","unstructured":"Takura T, Nitta K, Tsuchiya K, Kawanishi H (2023) Long-term effects of contrast media exposure on renal failure progression: a retrospective cohort study. BMC Nephrol. https:\/\/doi.org\/10.1186\/S12882-023-03194-2","journal-title":"BMC Nephrol"},{"key":"4542_CR53","doi-asserted-by":"publisher","first-page":"e12975","DOI":"10.7717\/PEERJ.12975\/SUPP-5","volume":"10","author":"Z Mei","year":"2022","unstructured":"Mei Z, Luo S, Chen P et al (2022) Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: A network meta-analysis. PeerJ 10:e12975. https:\/\/doi.org\/10.7717\/PEERJ.12975\/SUPP-5","journal-title":"PeerJ"},{"key":"4542_CR54","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3892\/ETM.2017.4678","volume":"14","author":"JX Li","year":"2017","unstructured":"Li JX, Jin EZ, Yu LH et al (2017) Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: a meta-analysis. Exp Ther Med 14:1568\u20131576. https:\/\/doi.org\/10.3892\/ETM.2017.4678","journal-title":"Exp Ther Med"},{"key":"4542_CR55","doi-asserted-by":"publisher","first-page":"e000127","DOI":"10.1136\/OPENHRT-2014-000127","volume":"1","author":"N Singh","year":"2014","unstructured":"Singh N, Lee JZ, Huang JJ et al (2014) Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart 1:e000127. https:\/\/doi.org\/10.1136\/OPENHRT-2014-000127","journal-title":"Open Heart"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04542-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04542-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04542-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:31:30Z","timestamp":1759843890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04542-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4542"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04542-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,4]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}